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specific sites in promoters of autoph-
agy-related genes and that fasting in-
deed increases such FoxO3 binding.
Conversely, the authors provide con-
vincing evidence that knockdown of
FoxO3 prevents starvation-induced
autophagy in isolated fibers and in
muscle in vivo.
Mammucari et al. (2007) further in-
vestigate themechanisms of this regu-
lation and discover that Bnip3, whose
transcription is controlled by FoxO3,
plays a major role in mediating the ef-
fects of FoxO3 and starvation on au-
tophagy. Bnip3 was previously found
to induce autophagy in cardiac myo-
cytes, where strikingly, this regulation
depends on Bnip3 localization to the
mitochondrial outer membrane (Ha-
macher-Brady et al., 2007). Further re-
search is therefore required to sort out
how much autophagy is induced as
a consequence of the mitochondrial
functions of Bnip3. Nonetheless, the
relevance of autophagy to muscle
physiology is undoubtedly empha-
sized by the observation that knock-
down of Atg8/LC3 partly reducesmus-
cle atrophy.
Together, these findings demon-
strate that FoxO3 directly and coor-
dinately activates the lysosomal and
proteasomal pathways inmusclewast-
ing. Critical proteins targeted for break-
down by either system remain to be
identified. Whether FoxO3 may control
alternative proteolytic routes (e.g., cal-
pains and caspases) that also seem to
be important in muscle wasting re-
mains to be determined.
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Metabolic component depletion in model systems results in life-span extension, which has been
difficult to reconcile with human metabolic pathologies. Recently, Rea et al. (2007) have shown
that mitochondrial electron transport chain RNAi phenotypes in the worm C. elegans are dose depen-
dent, providing an alternative view of mitochondrial function in longevity and metabolic diseases.Mitochondria not only are the ‘‘power-
houses of the cell’’ but also contribute
to numerous cellular functions, includ-
ing generation of free radicals, apopto-
sis, calcium signaling, and at least in
the wormC. elegans, aging. Abnormal-
ities in these dynamic organelles are
also associated with various human
metabolic diseases. The discrepancies
between human metabolic disorders
and the phenotypes displayed byC. elegans with knocked down or mu-
tated electron transport chain (ETC)
components have been a source of
confusion for quite some time. While
the human metabolic conditions re-
sult in detrimental phenotypes such
as seizures, ataxia, exercise intoler-
ance, cardiomyopathies, and shortened
life span, C. elegans ETC mutants
show a surprising variety of pheno-
types ranging from larval-arrestedCell Metabolism 6, D(atp-2(ua2), nuo-1(ua1)) to short-lived
(mev-1(kn1), gas-1(fc21)) to long-lived
(clk-1(qm30), isp-1(qm150)) (Rea, 2005).
Worms treated with RNAi against nu-
merous different nuclear-encoded mi-
tochondrial ETC and ATP synthase
genes often exhibit lengthened life
span (Dillin et al., 2002; Lee et al.,
2003; Curran and Ruvkun, 2007;
Chen et al., 2007). Rea et al. (2007) at-
tempt to resolve the disparity betweenecember 2007 ª2007 Elsevier Inc. 427
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Previewsincreased life span in worms due to
ETC knockdown and similar defects
in humans that result in disease. The
authors explored the hypothesis that
increased longevity due to deficiencies
within the ETC follows a bell-shaped
curve (Figure 1A), a proposed ‘‘mito-
chondrial threshold effect.’’ Using
dilution-based dsRNA for the ETC
gene atp-3, the oligomycin sensitiv-
ity-conferring protein/delta subunit
of the ATP synthase, a window of in-
creased life span was observed, sug-
gesting that a mitochondrial threshold
effect may be largely responsible for
the contrasting phenotypes.
The mitochondrial threshold effect
theory suggests that mitochondria
are able to function under compro-
mised conditions (for example, low
levels of mutated mtDNA or hetero-
plasmy) up to a certain point. Beyond
this threshold, the cells are no longer
able to cope and suffer a loss of mito-
chondrial function and cell viability
(Wallace, 1986). This theory attempts
to explain the elusive relationship
between metabolic genotype and the
resulting phenotype.
The recent work by Rea and
colleagues (2007) employs a 12-point
dilution series of bacteria expressing
dsRNA toward the gene of interest.428 Cell Metabolism 6, December 2007 ªFor atp-3, they found that the maximal
life-span extension of 70% was ob-
served at a 1:10 dilution. At higher con-
centrations of atp-3 dsRNA, theworms
were very small and life spanwas short-
ened (depicted in Figure 1A). Based on
this evidence, the authors propose that
under certain circumstances of partial
knockdown due to RNAi dilution, max-
imum life span can be achieved.
Interestingly, however, theothermito-
chondrial ETC genes associated with
longevity that were tested, cco-1, isp-1,
and nuo-2, also showed a graded in-
crease in life span, but none exhibited a
life span shorter than wild-type, even
when fed undiluted RNAi. The authors
also took advantage of RNAi-hyper-
sensitive mutant worm strains; how-
ever, treatment of these strains with
RNAi against cco-1, isp-1, and nuo-2
did not result in the bell-shaped life-
span curve observed for atp-3 RNAi,
nor did it result in a shift in sensitivity.
Therefore, there could be a detrimental
side effect (shortened life span) to
severe knockdown of the ATP syn-
thase that is not shared with severe
knockdown of complex I, III, and IV
components.
Metabolic theories of aging often
cite the fact that mitochondria produce
most of the cell’s damaging free radi-2007 Elsevier Inc.cals as an explanation for the ob-
served effects. The ‘‘free radical theory
of aging’’ could explain the ETC RNAi
life-span results or phenotypes in
terms of a proposed oxidative stress
response or reduced free radical pro-
duction. However, Rea et al. (2007)
and others (Lee et al., 2003) have yet
to find a connection between oxidative
stress and the longevity phenotype. In
the current study, they find no signifi-
cant correlation between the amount
of protein oxidative damage and lon-
gevity of worms fed atp-3 RNAi. More-
over, they did not observe decreased
or left-shifted life span in skn-1mutant
worms, which exhibit increased oxi-
dized protein levels, because skn-1 is
a key transcription factor responsible
for regulating oxidative stress defense
(An and Blackwell, 2003). Therefore,
the growing body of results from differ-
ent groups suggests that it is not that
the stochastic accumulation of free
radicals throughout the life span of an
animal accelerates the aging process.
Alternatively, a different metabolic by-
product of mitochondrial metabolic
activity, distinct from free radicals,may
be at the source of aging.
An underlying feature of the ‘‘rate of
living’’ theory of aging suggests that
the amount of the increase in lifeFigure 1. Dilution and Timing of Mitochondrial Electron Transport Chain RNAi Determines Longevity
(A) Different RNAi concentrations result in differentmean life-span curves. Relativemean life-span curves resulting from electron transport chain (ETC)
component knockdown via RNAi at increasing concentrations of dsRNA-expressing bacteria are depicted. atp-3 RNAi, shown in red, has a peak
increase in life span at a 1:10 dilution, while undiluted concentrations prove to be detrimental to life span. nuo-2 RNAi (blue) exhibits an increasing
life-span response with increasing concentrations of RNAi bacteria. mev-1 RNAi (green), which targets an ETC gene that has not been shown to
cause increased life span, does not exhibit an increase in life span at any concentration of RNAi.
(B) Timing requirements for ETC RNAi. C. elegans life span from egg through four larval stages to adulthood is shown at the left. Colored areas rep-
resent different times/stages that RNAi toward ETC components is administered. Feeding RNAi throughout the whole life (green area) results in an
increased life span (green line). RNAi knockdown during development only (yellow area) increases life span (yellow line). RNAi for the L3/L4 window of
development (red area) also increases life span, whereas RNAi during adulthood only (blue area) has no effect on life span.
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is correlated to the amount of time that
metabolism is actually reduced. This
aspect of the metabolic theory was
questioned when it was discovered
that mitochondrial function only needs
to be reduced during the larval stages
of the developing worm for life-span
extension to occur (Dillin et al., 2002).
From this work, it was hypothesized
that during larval development, a regu-
latory signal is established and some-
how maintained for the remainder of
the animal’s life, even if the missing
mitochondrial components are rein-
stated (Figure 1B). Expanding upon
this work, Rea et al. (2007) further de-
fine the timing of this execution point
to a specific period during the worm’s
larval development, the L3/L4 period
of the life cycle. Much like in previous
studies, RNAi of mitochondrial com-
ponents during adulthood, no matter
what the dilution, had no effect on life
span.
It will be of critical importance to
determine precisely what is monitored
and established during the L3/L4 larval
stage as the signal for mitochondrial
perturbation that results in increased
longevity. Tsang and Lemire (2002)
previously proposed an energy-sensing
checkpoint that monitors mitochondrial
status as an explanation for the L3/L4
arrest associated with mitochondrial
mutations or other mitochondrial per-
turbations. It is during this time period
that energy demands are high due to
the proliferating germline and that,indeed, mitochondrial numbers in the
worm expand the most (Tsang et al.,
2001). If energetic requirements can-
not be met, larval arrest results. The
L3/L4 arrest leads Rea and colleagues
(2007) to propose a cell-cycle role in
the mitochondrial longevity pheno-
type. This is an interesting model given
that p53 has recently been shown to
regulate mitochondrial activity (Ma-
toba et al., 2006). However, this cell-
cycle-based model would have to
take into account specific cell types
as being responsible for the mitochon-
dria-related longevity because by the
L3/L4 transition, almost all of the 959
cells of the animal are postmitotic.
Therefore, the cell-cycle regulation of
ETC-mediated longevity would likely
have to be cell type specific. In the fu-
ture, it will be important to understand
the energetic requirements during this
transition that might serve as the signal
to reduce the aging process and the
cells and tissue types in which re-
duced mitochondrial function must
act to promote longevity.
In conclusion, the role of mitochon-
drial function and longevity is turning
out to be much more complex than
originally postulated. The work of Rea
et al. (2007) raises important points
about the relationship between mito-
chondrial component knockdown and
human pathologies, as well as wide-
reaching issues for RNAi. It illuminates
the necessity of considering the level
of RNAi administered and the analysis
of the phenotypic threshold. This workCell Metabolism 6, Dprovides the basis for screening or
reevaluating genes that cause larval ar-
rest in a way that recreates something
of a phenotypically ‘‘weak allele.’’ Ap-
parently, not only the level ofmitochon-
drial gene reduction must be finely
tuned, but also the timing of reduction
as well, to generate specific life-span
phenotypes.
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